Your search history is turned on.
Date: November 10, 2023 Jurisdictions: All jurisdictions
HAVN LIFE SCIENCES Inc. Announces Cease Trade Order VANCOUVER, BC November 10, 2023 - HAVN Life Sciences Inc. (CSE: HAVN) (OTC:HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life"), announces that on November 9, 2023, the British Columbia Securities Commission (the BCSC) has issued a general "failure to file" cease trade order pursuant to National P...
Date: October 26, 2023 Jurisdictions: All jurisdictions
HAVN LIFE SCIENCES Inc. Announces Filing of Annual Report by November 10, 2023 VANCOUVER,BC October 25, 2023- Vancouver BC - HAVN Life Sciences Inc. (CSE: HAVN) (OTC:HAVLF) (FSE: 5NP) (the Company or HAVN Life), reports that the Company's external auditor has advised that it now expects to complete its audit and release its audit opinion and ...
Date: October 17, 2023 Jurisdictions: All jurisdictions
HAVN LIFE SCIENCES Inc. Announces Filing of Annual Report by November 10, 2023 VANCOUVER,BC October 13, 2023- Vancouver BC - HAVN Life Sciences Inc. (CSE: HAVN) (OTC:HAVLF) (FSE: 5NP) (the Company or HAVN Life), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, r...
Date: October 12, 2023 Jurisdictions: All jurisdictions
HAVN LIFE SCIENCES Inc. PROVIDES BI-WEEKLY MCTO STATUS UPDATE October 11, 2023- Vancouver BC - HAVN Life Sciences Inc. (CSE: HAVN) (OTC:HAVLF) (FSE: 5NP) (the Company or HAVN Life), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is providing a default status repo...
Date: September 28, 2023 Jurisdictions: All jurisdictions
HAVN LIFE SCIENCES Inc. PROVIDES BI-WEEKLY MCTO STATUS UPDATE September 27, 2023- Vancouver BC - HAVN Life Sciences Inc. (CSE: HAVN) (OTC:HAVLF) (FSE: 5NP) (the Company or HAVN Life), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is providing a default status re...
Date: September 19, 2023 Jurisdictions: All jurisdictions
HAVN LIFE SCIENCES Inc. PROVIDES BI-WEEKLY MCTO STATUS UPDATE September 15, 2023- Vancouver BC - HAVN Life Sciences Inc. (CSE: HAVN) (OTC:HAVLF) (FSE: 5NP) (the Company or HAVN Life), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is providing a default status repo...
Date: September 2, 2023 Jurisdictions: All jurisdictions
FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company HAVN Life Sciences Inc. (the Company) 605 130 Brew Street Port Moody, British Columbia V3H 03 Item 2 Date of Material Change August 29, 2023 Item 3 News Release The Company disseminated a news release in respect of the materia...
HAVN ANNOUNCES ANTICIPATED LATE FILING OF FINANCIAL STATEMENTS AND APPLICATION FOR MANAGEMENT CEASE TRADE ORDER August 29, 2023 Vancouver, BC HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the Company or HAVN Life), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural he...
Date: July 27, 2023 Jurisdictions: All jurisdictions
HAVN ANNOUNCES CHANGE OF AUDITOR Vancouver, BC July 24, 2023 HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the Company or HAVN Life), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that, effective as of July 4, 2023 (the Effective...
To: Davidson & Company LLP, Chartered Professional Accountants De Visser Gray LLP, Chartered Professional Accountants Re: HAVN Life Sciences Inc. (the Company) Notice of Change of Auditor (the Notice) In compliance with Section 4.11 of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102), please be advise...